Drugs / Xiao Chai Hu Tang
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06055179 | Mar 2024 → Jun 2026 overdue | irinotecan toxicity | Guangzhou University of Traditional Chinese Medicine | Recruiting | No outcome recorded |
| — | NCT04926545 | Jul 2021 → Jul 2024 | cancer, diarrheal disease | Guangzhou University of Traditional Chinese Medicine | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Xiao Chai Hu Tang | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06055179 ↗ |
| Known as | XCHT | “Xiao Chai Hu Tang (XCHT)” NCT04926545 ↗1“Xiao Chai Hu Tang (XCHT)” NCT06055179 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Classical Chinese Formula Xiao Chai Hu Tang” NCT04926545 ↗ |
| Route | Oral | “will be orally administrated” NCT04926545 ↗ |